Skip to main content

Advertisement

Log in

Correlation between Choline Peak at MR Spectroscopy and Calcium-Sensing Receptor Expression Level in Breast Cancer: A Preliminary Clinical Study

  • Research Article
  • Published:
Molecular Imaging and Biology Aims and scope Submit manuscript

Abstract

Purpose

The calcium-sensing receptor (CaSR) is overexpressed in many pathological states including breast cancer. Since choline kinase may be activated in breast cancer cells by CaSR resulting in increased phosphocholine production, we sought to correlate the total choline peak in breast lesions as measured by in vivo proton magnetic resonance spectroscopy (1H-MRS) with the CaSR expression levels in surgical specimens.

Procedures

Thirty-six patients with breast lesions were MR scanned at 3T scanner. Tumour morphology and DCE-MR kinetics were evaluated. 1H-MRS was applied for Cho detection and compared with the CaSR immunohistochemistry analysis (score 0–5) on surgical breast specimens.

Results

Thirty-four lesions demonstrated a DCE malignant kinetics curve (types 2 and 3), while two lesions showed a benign (type 1). Twenty of the 23 breast cancer lesions (87 %) with a consistent Cho peak expressed a CaSR score of 3–5, and ten of the 11 breast lesions negative for Cho (91 %) had a CaSR score of 1–2. The two benign lesions showed a non-uniform/weak intense expression of the CaSR (score 3) with a consistent Cho peak.

Conclusions

The presence or absence of choline peak evaluated by 1H-MRS, well correlated with the expression of CaSR in patients with breast lesions (p < 0.01), supports the hypothesis that CaSR may play an important role in the production of choline in breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.

Similar content being viewed by others

References

  1. Ward DT, Riccardi D (2012) New concepts in calcium-sensing receptor pharmacology and signalling. Br J Pharmacol 165:35–48

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Diez-Fraile A, Lammens T, Benoit Y et al (2013) The calcium-sensing receptor as a regulator of cellular fate in normal and pathological conditions. Curr Mol Med 13:282–295

    Article  CAS  PubMed  Google Scholar 

  3. Ward DT (2004) Calcium receptor-mediated intracellular signalling. Cell Calcium 35:217–228

    Article  CAS  PubMed  Google Scholar 

  4. Mihai R, Stevens J, McKinney C et al (2006) Expression of the calcium receptor in human breast cancer-a potential new marker predicting the risk of bone metastases. Eur J Surg Oncol 32:511–515

    Article  CAS  PubMed  Google Scholar 

  5. Warner E, Plewes DB, Shumak RS et al (2001) Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 19:3524–3531

    CAS  PubMed  Google Scholar 

  6. Warner E, Messersmith H, Causer P et al (2008) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Intern Med 148:671–679

    Google Scholar 

  7. Houssami N, Hayes DF (2009) Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? Cancer J Clin 59:290–302

    Article  Google Scholar 

  8. Su MY, Yu HJ, Carpenter PM et al (2005) Pharmacokinetic parameters analyzed from MR contrast enhancement kinetics of multiple malignant and benign breast lesions detected in the same patients. Technol Cancer Res Treat 4:255–263

    Article  PubMed  Google Scholar 

  9. Aboagye EO, Bhujwall ZM (1999) Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 59:80–84

    CAS  PubMed  Google Scholar 

  10. Lean C, Doran S, Somorjai RL et al (2004) Determination of grade and receptor status from the primary breast lesion by magnetic resonance spectroscopy. Technol Cancer Res Treat 3:551–556

    Article  PubMed  Google Scholar 

  11. Huang C, Hydo LM, Liu S et al (2009) Activation of choline kinase by extracellular Ca2+ is Ca(2+)-sensing receptor, Galpha12 and Rho-dependent in breast cancer cells. Cell Signal 21:1894–1900

    Article  CAS  PubMed  Google Scholar 

  12. Brown EM, MacLeod RJ (2001) Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81:239–297

    CAS  PubMed  Google Scholar 

  13. O’Flynn EA, DeSouza NM (2011) Functional magnetic resonance: Biomarkers of response in breast cancer. Breast Cancer Res 13:405

    Article  PubMed Central  Google Scholar 

  14. Baek HM, Lee YJ (2014) Feasibility of MR spectroscopy for characterizing malignant breast lesions using a clinical 3-T scanner. Breast Cancer Jan 4. [Epub ahead of print]

  15. Cheng I, Klingensmith ME, Chattopadhyay N et al (1998) Identification and localization of the extracellular calcium-sensing receptor in human breast. J Clin Endocrinol Metab 83:703–707

    CAS  PubMed  Google Scholar 

  16. Huang W, Fisher PR, Dulaimy K et al (2004) Detection of breast malignancy: Diagnostic MR protocol for improved specificity. Radiology 232:585–591

    Article  PubMed  Google Scholar 

  17. Grinde MT, Skrbo N, Moestue SA et al (2014) Interplay of choline metabolites and genes in patient-derived breast cancer xenografts. Breast Cancer Res 16:R5

    Article  PubMed Central  PubMed  Google Scholar 

  18. Brennan SC, Thiem U, Roth S et al (2013) Calcium sensing receptor signalling in physiology and cancer. Biochim Biophysa Acta 1833:1732–1744

    Article  CAS  Google Scholar 

  19. Meisamy S, Bolan PJ, Baker EH et al (2004) Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo 1H MR spectroscopy a pilot study at 4T. Radiology 233:424–431

    Article  PubMed  Google Scholar 

  20. Kumar M, Jagannathan NR, Seenu V et al (2006) Monitoring the therapeutic response of locally advanced breast cancer patients: Sequential in vivo proton MR spectroscopy study. J Magn Reson Imaging 24:325–332

    Article  PubMed  Google Scholar 

  21. Promkan M, Liu G, Patmasiriwat P et al (2011) BRCA1 suppresses the expression of survivin and promotes sensitivity to paclitaxel through the calcium sensing receptor (CaSR) in human breast cancer cells. Cell Calcium 49:79–88

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Mrs Teresa Morris, Coordinator of Aberdeen Biomedical Imaging, University of Aberdeen, UK, for his helpful revision of the manuscript, in particular for English editing.

Conflict of Interests

The authors declare that they have no conflict of interests.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gabriella Baio.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baio, G., Rescinito, G., Rosa, F. et al. Correlation between Choline Peak at MR Spectroscopy and Calcium-Sensing Receptor Expression Level in Breast Cancer: A Preliminary Clinical Study. Mol Imaging Biol 17, 548–556 (2015). https://doi.org/10.1007/s11307-015-0823-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11307-015-0823-y

Key words

Navigation